Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- LZ +27.3%, SKYT +24.4%, SNAP +20% (also partnership with Perplexity), FSLY +19.3%, COHR +18.9%, FWRD +17.6%, ECPG +17%, MTW +16.4%, RXST +15.6%, PEN +15.3%, HAE +12.4%, LNW +11.2%, SITM +11.1%, BLMN +11.1%, HRTG +11%, SN +11%, SEZL +10.3%, TTAM +10.3%, LFST +10.2%, MQ +9.6%, PLNT +9.5%, HL +9.4%, CAI +9.2%, EQX +9.1%, PLTK +8.8%, WK +8.5%, AEVA +8.3%, ARHS +8%, SPT +7.9%, APP +7.7% (also increase share repurchase program by $3.2 bln), HCC +7.5%, TPC +7.5%, MKSI +7.4%, DNUT +7.3%, RVMD +7.2%, ARRY +7.1%, YOU +7.1%, RDVT +6.4% (also $15 mln increase to share repurchase program), PCOR +6.2%, CPRX +6.2%, CPAY +6.2%, QDEL +6%, WW +5.4%, OSCR +5.3%, ARM +5.2%, EE +5.2%, SBSW +5.2%, ROK +5.1%, LYFT +4.9%, WMS +4.8%, PR +4.7%, MT +4.6%, KVYO +4.5%, COTY +4.5%, LGND +4.5%, ADPT +4.3%, CNR +4.3%, EPAM +4.1%, YETI +4.1%, AAON +4.1%, DLX +4%, IONQ +4% (also successfully deployed a citywide quantum network in Geneva, Switzerland), STVN +4%, SGI +4%, FRSH +3.9% (also expands enterprise service management), ACAD +3.8%, ACIW +3.7%, AWR +3.6%, ENS +3.5%, GVA +3.5%, AMPL +3.4%, APD +3.4%, FIG +3.3%, HLF +3.2%, MIAX +3.1%, ULCC +3.1%, QTWO +3.1%, ALB +3%, APA +3%, VECO +3%, AMCR +2.9%, GEO +2.9%, MIDD +2.9%, DYN +2.8%, NGVT +2.8%, BGS +2.8%, TIGO +2.7%, SATS +2.7%, MUR +2.6%, PRI +2.6%, PRVA +2.6%, USFD +2.6%, SDGR +2.4%, HST +2.4%, NOMD +2.3%, ALL +2.2%, SAFE +2.2%, TRMD +2.2%, PODD +2.2%, SBGI +2.1%
Other news:
- FRGE +65.8% (Charles Schwab has entered into a definitive agreement to acquire Forge Global Holdings (FRGE) in a transaction valued at approximately $660 million)
- YMT +9.9% (acquires Xunxi Technology)
- MTSR +8.3% (issues statement in response to litigation ruling)
- NXDR +6% (appoints new CFO)
- FDMT +5.7% (interim 1.5- to 3.5-year data from the Phase 1/2 PRISM clinical trial evaluating 4D-150 in patients with wet age-related macular degeneration; pricing of an underwritten offering of 8,385,809 shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase 1,128,949 shares of common stock)
- ASST +5.5% (upsizing and pricing of initial public offering)
- CGAU +4.7% (TSX acceptance of normal course issuer bid)
- RM +2.8% (CEO to retire, names new CEO)
- DVAX +2.5% (exclusive license agreement for Vaxart's oral COVID-19 vaccine program)
- SLSR +2.5% (pre-feasibility study results and Maiden Mineral Reserve for the Warintza Project)
- GRND +2.4% (announces updates to Board of Directors)
- ILMN +2.2% (responds to updates from Chinese Ministry of Commerce)
- FRMI +2.2% (signs $150 million construction advance agreement with first client)
- UMAC +1.8% (continues domestic expansion)
- WRD +1.7% (lists on Hong Kong Stock Exchange)
- RKLB +1.3% (successful launch of Electron mission)